Picture of biOasis Technologies logo

BTI biOasis Technologies Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for biOasis Technologies, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

2018
February 28th
2019
February 28th
2020
February 29th
2021
February 28th
2022
February 28th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5.31-3.47-4.060.698-2.96
Depreciation
Amortisation
Non-Cash Items1.47-0.397-0.0051.26-0.329
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.1020.5680.692-0.248-0.402
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-3.67-3.23-3.31.77-3.64
Capital Expenditures-0.108-0.002
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00.39500.0070
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-0.1080.39300.0070
Financing Cash Flow Items-0.09
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.93.532.490.3122.64
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.1240.682-0.7842.16-1.01

Or unlock with your email

Or unlock with your email